{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T02:15:12Z","timestamp":1761185712784,"version":"build-2065373602"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.parkreldis.2023.105370","type":"journal-article","created":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T22:13:34Z","timestamp":1678832014000},"page":"105370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Heterozygous pathogenic variant in GCH1 associated with treatable severe spastic tetraplegia: Expert opinion"],"prefix":"10.1016","volume":"109","author":[{"given":"Philippe A.","family":"Salles","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2023.105370_bib1","first-page":"215","article-title":"Hereditary progressive dystonia with marked diurnal fluctuation","volume":"14","author":"Segawa","year":"1976","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.parkreldis.2023.105370_bib2","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/ng1194-236","article-title":"Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene","volume":"8","author":"Ichinose","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.parkreldis.2023.105370_bib3","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.pediatrneurol.2004.03.017","article-title":"Misdiagnoses in children with dopa-responsive dystonia","volume":"31","author":"Jan","year":"2004","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.parkreldis.2023.105370_bib4","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1002\/ana.10630","article-title":"Autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (Segawa disease)","volume":"54","author":"Segawa","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2023.105370_bib5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.braindev.2010.10.015","article-title":"Hereditary progressive dystonia with marked diurnal fluctuation","volume":"33","author":"Segawa","year":"2011","journal-title":"Brain Dev."},{"key":"10.1016\/j.parkreldis.2023.105370_bib6","doi-asserted-by":"crossref","first-page":"e876","DOI":"10.1212\/CPJ.0000000000001125","article-title":"Recognizing atypical dopa-responsive dystonia and its mimics","volume":"11","author":"Salles","year":"2021","journal-title":"Neurol. Clin. Pract."},{"key":"10.1016\/j.parkreldis.2023.105370_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1353-8020(00)00084-5","article-title":"The long-term response to levodopa in dopa-responsive dystonia","volume":"8","author":"Hwang","year":"2001","journal-title":"Parkinsonism Relat. Disorders"},{"key":"10.1016\/j.parkreldis.2023.105370_bib8","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/jnnp.2008.155861","article-title":"Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients","volume":"80","author":"Trender-Gerhard","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2023.105370_bib9","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1001\/archneurol.2012.574","article-title":"Dopa-responsive dystonia revisited: diagnostic delay, residual signs, and nonmotor signs","volume":"69","author":"Tadic","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.parkreldis.2023.105370_bib10","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1093\/brain\/awu179","article-title":"International Parkinson's Disease Genomics Consortium and UCL-exomes consortium, Parkinson's disease in GTP cyclohydrolase 1 mutation carriers","volume":"137","author":"Mencacci","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2023.105370_bib11","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/nrneurol.2015.86","article-title":"Dopa-responsive dystonia - clinical and genetic heterogeneity","volume":"11","author":"Wijemanne","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.parkreldis.2023.105370_bib12","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1001\/archneur.55.10.1320","article-title":"Long-term follow-up of levodopa responsiveness in generalized dystonia","volume":"55","author":"Dewey","year":"1998","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.parkreldis.2023.105370_bib13","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/mds.21377","article-title":"Adult-onset dystonia: atypical manifestation of Segawa disease","volume":"22","author":"Regula","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2023.105370_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.906","article-title":"Atypical presentation of dopa-responsive dystonia in Taiwan","volume":"8","author":"Weng","year":"2018","journal-title":"Brain Behav."},{"key":"10.1016\/j.parkreldis.2023.105370_bib15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1136\/jnnp.2007.128413","article-title":"Frequency of GCH1 deletions in Dopa-responsive dystonia","volume":"79","author":"Zirn","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2023.105370_bib16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.parkreldis.2020.03.019","article-title":"Autosomal dominant GCH1 mutations causing spastic paraplegia at disease onset","volume":"74","author":"Wassenberg","year":"2020","journal-title":"Parkinsonism Relat. Disorders"},{"key":"10.1016\/j.parkreldis.2023.105370_bib17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/cge.13955","article-title":"GCH1 mutations in hereditary spastic paraplegia","volume":"100","author":"Varghaei","year":"2021","journal-title":"Clin. Genet."},{"key":"10.1016\/j.parkreldis.2023.105370_bib18","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/mds.26527","article-title":"Nomenclature of genetic movement disorders: recommendations of the international Parkinson and movement disorder society task force","volume":"31","author":"Marras","year":"2016","journal-title":"Mov. Disord."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802023000937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802023000937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:27:49Z","timestamp":1761179269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802023000937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":18,"alternative-id":["S1353802023000937"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105370","relation":{},"ISSN":["1353-8020"],"issn-type":[{"type":"print","value":"1353-8020"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heterozygous pathogenic variant in GCH1 associated with treatable severe spastic tetraplegia: Expert opinion","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105370","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105370"}}